[Quantitative analysis of nuclear proteome in apoptosis hepatoma cells induced by hydroxycamptothecin]

Yu Rong Yan1, Yu Rong Fu, Zong Yin Qiu

  • 1Chongqing University of Medical Science, Key Laboratory of Laboratory Medical Diagnostics, Ministry of Education, Chongqing 400016.

Fen Zi Xi Bao Sheng Wu Xue Bao = Journal of Molecular Cell Biology
|June 24, 2008
PubMed

Insights

Hydroxycamptothecin induces apoptosis in hepatoma cells, altering 42 nuclear proteins. This quantitative proteomic study reveals key proteins involved in cell proliferation, metabolism, and apoptosis.

Area of Science:

  • Proteomics
  • Cell Biology
  • Pharmacology

Context:

  • Hydroxycamptothecin is a chemotherapeutic agent.
  • Understanding its subcellular effects is crucial for drug development.
  • Hepatoma cells are a model for liver cancer research.

Purpose:

  • To investigate the quantitative proteomic changes in hepatoma cell nuclei after hydroxycamptothecin treatment.
  • To identify differentially expressed nuclear proteins involved in hydroxycamptothecin-induced apoptosis.

Summary:

  • Hepatoma cells were treated with hydroxycamptothecin to induce apoptosis.
  • Nuclear proteins were isolated, labeled using cleavable isotope-coded affinity tag (c-ICAT) reagent, and analyzed by shotgun proteomics.
  • A total of 42 nuclear proteins showed significant expression changes (P<0.05), with 30 upregulated and 12 downregulated.

Impact:

  • Identified 42 differentially expressed nuclear proteins, providing a quantitative proteomic foundation for hydroxycamptothecin's action.
  • These proteins are implicated in critical cellular processes including proliferation, apoptosis, differentiation, and metabolism.
  • Findings contribute to understanding hydroxycamptothecin's mechanism of action at a subcellular level.

Related Concept Videos